Clinical trial
Remifentanil Intravenous Patient-controlled Labor Analgesia for Nulliparous Women
NCT00710086 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Remifentanil Intravenous Patient-controlled Labor Analgesia for Nulliparous Women
- Lead sponsor
- Nanjing Medical University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- September 30, 2009
- Enrollment
- 1,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.